trending Market Intelligence /marketintelligence/en/news-insights/trending/VWmn7Wk3BlrCqFKKZ_ELAA2 content esgSubNav
Log in to other products


Looking for more?

Contact Us
In This List

LogicBio Therapeutics appoints 2 directors


Climate Credit Analytics: Linking climate scenarios to financial impacts


Global M&A Infographic Q1 2021


Q1 2021 Global Capital Markets Activity: SPAC IPOs, Issuance in Consumer Discretionary Sector Surge


COVID-19 Impact & Recovery: Private Equity

LogicBio Therapeutics appoints 2 directors

LogicBio Therapeutics Inc. appointed Richard Moscicki and Michael Wyzga as directors.

Moscicki is the executive vice president for science and regulatory advocacy and the chief medical officer at Pharmaceutical Research and Manufacturers of America.

Wyzga is the CEO and president of MSW Consulting Inc., a private biotechnology consulting firm.

LogicBio Therapeutics is a genome-editing company that develops medicines for rare diseases in patients with unmet medical needs.